Evidence map›Paper›PMID 22171062›Full record

ArticleGlycobiology2012

Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.

Michelle L Colgrave, Hayley J Snelling, Brian J Shiell, Yan-Ru Feng, Yee-Peng Chan, Katharine N Bossart, Kai Xu, Dimitar B Nikolov, Christopher C Broder, Wojtek P Michalski

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Impact of Protein Glycosylation on the Design of Viral Vaccines.Advances in biochemical engineering/biotechnology · 2021
    Review
  8. Vaccines to Emerging Viruses: Nipah and Hendra.Annual review of virology · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Therapeutic potential of targeting the Eph/ephrin signaling complex.The international journal of biochemistry & cell biology · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Michelle L ColgraveQueensland Bioscience Precinct, CSIRO Livestock Industries, St Lucia, QLD 4067, Australia.
Hayley J Snelling
Brian J Shiell
Yan-Ru Feng
Yee-Peng Chan
Katharine N Bossart
Kai Xu
Dimitar B Nikolov
Christopher C Broder
Wojtek P Michalski
Uniformed Services University of the Health Sciences · USAustralian Centre for Disease Preparedness · AUCommonwealth Scientific and Industrial Research Organisation · AUMemorial Sloan Kettering Cancer Center · USBoston University · US

Funding

Vaccines and Therapeutics for Nipah and Hendra virusU01AI077995 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 2008 to 2012
$5.5M
Nipah Virus and Hendra Virus Entry and Virion AssemblyR01AI054715 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 2006 to 2016
$3.1M
NIAID NIH HHS AI054715NIAID NIH HHS AI077995NIAID NIH HHS R01 AI054715NIAID NIH HHS U01 AI077995
6 · The paper itself

Abstract

Hendra virus (HeV) continues to cause morbidity and mortality in both humans and horses with a number of sporadic outbreaks. HeV has two structural membrane glycoproteins that mediate the infection of host cells: the attachment (G) and the fusion (F) glycoproteins that are essential for receptor binding and virion-host cell membrane fusion, respectively. N-linked glycosylation of viral envelope proteins are critical post-translation modifications that have been implicated in roles of structural integrity, virus replication and evasion of the host immune response. Deciphering the glycan composition and structure on these glycoproteins may assist in the development of glycan-targeted therapeutic intervention strategies. We examined the site occupancy and glycan composition of recombinant soluble G (sG) glycoproteins expressed in two different mammalian cell systems, transient human embryonic kidney 293 (HEK293) cells and vaccinia virus (VV)-HeLa cells, using a suite of biochemical and biophysical tools: electrophoresis, lectin binding and tandem mass spectrometry. The N-linked glycans of both VV and HEK293-derived sG glycoproteins carried predominantly mono- and disialylated complex-type N-glycans and a smaller population of high mannose-type glycans. All seven consensus sequences for N-linked glycosylation were definitively found to be occupied in the VV-derived protein, whereas only four sites were found and characterized in the HEK293-derived protein. We also report, for the first time, the existence of O-linked glycosylation sites in both proteins. The striking characteristic of both proteins was glycan heterogeneity in both N- and O-linked sites. The structural features of G protein glycosylation were also determined by X-ray crystallography and interactions with the ephrin-B2 receptor are discussed.

Indexed as

Hendra VirusAmino Acid MotifsAmino Acid SequenceCarbohydrate ConformationCarbohydrate SequenceCrystallography, X-RayElectrophoretic Mobility Shift AssayGlycosylationHEK293 CellsHeLa CellsHumansLectinsModels, MolecularMolecular Sequence DataPeptide FragmentsPolysaccharidesattachment protein GLectinsPeptide FragmentsPolysaccharidesReceptor, EphB2Recombinant ProteinsViral Envelope Proteins

Identifiers

PMID22171062
PMCPMC3287018
OpenAlexW2123817807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.